Matthew Stuible
Ottawa, ON K1A0R6, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Multifunctional ACE2-nanobody fusion design for pan-specific neutralization and cardiovascular protection in SARS coronavirus infection.
Journal: Antimicrobial agents and chemotherapy
Published: March 23, 2026
Immunogenicity of Sulfated Lactosyl Archaeol Archaeosome-Adjuvanted Versus Non-Adjuvanted SARS-CoV-2 Spike Booster Vaccines in Young and Aged Balb/c Mice.
Journal: Vaccines
Published: October 31, 2025
Durability of DNA-LNP and mRNA-LNP vaccine-induced immunity against SARS-CoV-2 XBB.1.5.
Journal: NPJ vaccines
Published: October 15, 2025
Endogenous Retrovirus-Like Particle-Deficient CHO Cells Can be Generated by CRISPR or shRNA and Enriched Based on Cell-Surface Expression of Retroviral Envelope Protein.
Journal: Biotechnology and bioengineering
Published: May 01, 2025
Optimized Production of Virus-like Particles in a High-CHO-Cell-Density Transient Gene Expression System for Foot-and-Mouth Disease Vaccine Development.
Journal: Vaccines
Published: April 01, 2025
Erratum: Lipid nanoparticle encapsulation of a Delta spike-CD40L DNA vaccine improves effectiveness against Omicron challenge in Syrian hamsters.
Journal: Molecular therapy. Methods & clinical development
Published: January 06, 2025
Reduced cross-protective potential of Omicron compared to ancestral SARS-CoV-2 spike vaccines against potentially zoonotic coronaviruses.
Journal: Npj viruses
Published: July 23, 2024
Modifying the glycosylation profile of SARS-CoV-2 spike-based subunit vaccines alters focusing of the humoral immune response in a mouse model.
Journal: Communications medicine
Published: July 10, 2024
Recombinant Protein Production from Stable CHO Cell Pools.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: June 26, 2024
Last Updated: 09/26/2026